FDA clears SparingVision’s investigational new drug application to treat ocular diseases
SparingVision today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…
December 1, 2022 - 4 minutes
SparingVision today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…